Background: Preterm birth alters the development of all organs, including the heart. Young adults born preterm have altered cardiac geometry (cardiac remodelling) and impaired cardiac function. Certain categories of cardiac remodelling are strongly associated with increased cardiovascular morbidity in adults. At present, the time of onset and the pattern of cardiac remodelling in preterm infants is unknown. The aim of this study is to describe and classify left ventricle (LV) geometry and LV function of very preterm infants at 36 weeks postmenstrual age.
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Methods: LV end diastolic volume index (LVEDVI), LV mass index (LVMI), relative wall thickness (RWT) and end-diastolic internal diameter (LVIDd) were prospectively obtained with echocardiography in preterm infants born at <30 weeks gestation. Their LV geometry was characterised and classified according to international classification. LV function was assessed with speckle tracking derived peak longitudinal systolic strain (LS) and Doppler estimated LV filling pressure (LVFP).
Results: Eighty-three infants with a mean gestation of 27 weeks and 41 control infants born at 36 weeks were analysed. LVEDVI (34.5 versus 23.4 mL/m 2 ; P < 0.001), LVMI (36.2 versus 32.1 gm/m 2 ; P < 0.001), LVIDd (21.6 versus 20.0 mm; P < 0.001) and LVFP (13.9 versus 10.2; P < 0.001) were significantly higher in very preterm infants. LS was comparable between the two groups.
LV phenotype was normal in 55% very preterm infants. Physiological enlargement and dilated hypertrophy were seen in 24% and 21%
Conclusion: At 36 weeks postmenstrual age, very preterm infants have significantly dilated, hypertrophied and more spherical LV with impaired diastolic function compared to the control group.
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Background: Remifentanil is a potent short acting opioid which is rapidly metabolised by mother and fetus. Despite positive data published in a meta-analysis, remifentanil is not used widely in Victoria for labour analgesia. Ballarat Health Services has approximately 1,400 births per annum with Remifentanil being offered as patient controlled analgesia to women in labour. The aim of this retrospective cohort study was to determine the efficacy, patient satisfaction and maternal and neonatal adverse effects profile of remifentanil.
Methods: A retrospective cohort study was conducted over a period of 6 months, from January to June 2018 of all births at a single regional centre. Subjects were identified via routinely collected birth data. Dose of Remifentanil was 20mcg/mL. Four parameters had data collected including maternal demographics, labour, analgesia and neonatal outcomes.
Results: Of 641 births, 45 patients used remifentanil. Patients were 19-40 years old with BMIs of 20-38 and generally over 37 weeks gestation. 2 patients required Remifentanil for management of a FDIU. 17 patients presented in spontaneous labour with 18 having inductions mainly due to high BMI and GDM. 67% of patient used Nitrous prior to Remifentanil with 18% of patients requiring an epidural. 7% required an instrumental delivery subsequent to remifentanyl. 100% of neonates had a 5-minute APGAR >6 with 7% requiring a SCN admission and 2% of neonates requiring resuscitation at birth.
Conclusions: This audit indicates that the use of Remifentanil in labour was associated with a high subsequent vaginal delivery rate and no significant adverse neonatal outcomes as a direct result. There is only limited information on gut microbiota in neonates with congenital gastrointestinal surgical conditions (NCGISC) available.
GUT MICROBIOTA IN NEONATES WITH CONGENITAL GASTROINTESTINAL SURGICAL CONDITIONS
Methods: Prospective study comparing gut microbiota of 32 NCGISC versus 40 healthy term infants (HI) using 16S ribosomal RNA gene sequencing. Two stool samples were collected from each infant: at admission and one week later.
Results: The mean gestational age and birth weight were lower in NCGISC: GA [(37.4weeks (1. 2) vs 38.8 (1.4); P < 0.001]; BW [2996g (SD 475.6) vs 3315.5g (SD 425.5); P = 0.003]. Alpha diversity: Bacterial richness between NCGISC and HI was similar at week1 (P = 0.366). Richness decreased in both NCGISC and HI from week1 to week2 (both P < 0.001). Bacterial diversity showed significant reduction in NCGISC at week2 compared to week1 (P < 0.05) but remained stable in HI. Beta diversity: By week1, beta diversity analysis based on both Bray-Curtis and weighted Unifrac dissimilarities showed that NCGISC had similar community structures to HI (P > 0.05). By week2, the community structures of NCGISC were significantly different compared to HI at week2 (P < 0.05) and to NCGISC at week1 (P < 0.05). Proteobacteria was dominant phylum in both NCGISC and HI at week1. At week2, NCGISC displayed higher levels of Proteobacteria and Firmicutes, whereas Actinobacteria, Firmicutes and Bacteroidetes dominated HI. Bifidobacterium was the most abundant genus at week2 in HI. In contrast, Staphylococcus, Bradyrhizobium, Escherichia-Shigella and Streptococcus were the most abundant genera found in NCGISC.
Conclusions: During hospitalisation, neonates with congenital gastrointestinal surgical conditions develop gut dysbiosis with enrichment of Proteobacteria and depletion of Bacteroidetes and Bifidobacterium.
